3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
40
Myelodysplastic Syndromes
8
Leukemia, Biphenotypic, Acute
6
Leukemia
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Neoplasm, Residual
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid
2
Blast Crisis
2
Sarcoma, Myeloid
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Hematologic Neoplasms
1
Down Syndrome
1
Congenital Abnormalities
1
Carcinoma, Hepatocellular
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
9
Biopsy
5
Specimen Handling
4
Prednisone
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
fludarabine
3
Vincristine
3
Etoposide
3
Doxorubicin
3
Brentuximab Vedotin
3
sodium-iodide symporter
2
pembrolizumab
2
fludarabine phosphate
2
cemiplimab
2
alectinib
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Rituximab
2
Positron-Emission Tomography
2
Photons
2
Mycophenolic Acid
2
Immunoglobulin G
2
Filgrastim
2
Disulfides
2
Cyclosporine
2
10-propargyl-10-deazaaminopterin
2
treosulfan
1
talimogene laherparepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
Idarubicin
×
1 year
×
Clear all
No trials found.